Åkesson, K.E.
Ganda, K.
Deignan, C.
Oates, M.K.
Volpert, A.
Brooks, K.
Lee, D.
Dirschl, D.R.
Singer, A.J.
Funding for this research was provided by:
Lund University
Article History
Received: 26 October 2021
Accepted: 18 February 2022
First Online: 24 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Kristina E. Åkesson is a consultant for Amgen, Renapharma, and UCB Pharma and is on the speakers’ bureau for Amgen. Kirtan Ganda has nothing to disclose. Cynthia Deignan is an employee and stockholder of Amgen. Mary K. Oates is an employee and stockholder of Amgen. Amy Volpert is an employee of BioScience Communications, which received funding from Amgen for this project. Keyla Brooks is an employee and stockholder of UCB Pharma. David Lee is a former employee and stockholder of Amgen and is currently an employee of Health Collaboration Partners LLC, a healthcare consulting firm. Douglas R. Dirschl is a consultant for Stryker, BONESUPPORT, SI-BONE, and Acumed. Andrea J. Singer has received research support from Radius and UCB Pharma; is a consultant for AgNovos, Amgen, Radius, and UCB Pharma; and is on the speakers’ bureau for Amgen and Radius.